Steep Hill Nixes Testing Labs Deal With Pazoo
Steep Hill Labs, a prominent marijuana testing company, has severed all contracts with New Jersey-based Pazoo, which had…
News July 5
Latest In: Stocks
Week in Review: California is official, GW’s epilepsy drug & Illinois resignation
California's recreational marijuana campaign makes the November ballot, GW Pharmaceuticals' MJ-based epilepsy drug could play a role in…
News July 1Medical Cannabis Company GW Pharma’s Stock Again Jumps
GW Pharmaceuticals – a publicly traded British medical cannabis company conducting clinical trials to determine how effective its…
News June 27
Chart of the Week: Monthly Recreational Marijuana Sales in U.S. Averaging $124M
By Eli McVey Colorado, Oregon and Washington State are averaging a combined $123.5 million in monthly recreational marijuana…
News June 27SEC Files Charges Over Alleged MMJ Investment Scam
Wall Street regulators filed civil fraud charges against a company and four people allegedly caught up in a…
News May 27
Week in Review: OH Lawmakers Okay MMJ, Nasdaq says No to MassRoots & MMJ for Vets
By John Schroyer and Omar Sacirbey Ohio lawmakers pass a medical marijuana bill in a bid to undercut…
News May 27Nasdaq shoots down MassRoots for stock listing
Denver-based MassRoots, the popular social network for cannabis enthusiasts, failed again to secure a public listing on the Nasdaq,…
News May 24FDA Grants U.K. Firm Incentives to Develop Cannabis-Based Drug
U.S. regulators granted GW Pharmaceuticals’ cannabis-based epilepsy drug “orphan” status, enabling the company to receive tax credits and…
News April 25AmeriCann Invests $6.7M in Massachusetts MJ Facilities
AmeriCann, a Denver medical marijuana company, is investing nearly $7 million in a dispensary and a grow facility in…
News April 14MassRoots Taking Another Stab at Nasdaq Listing
MassRoots, the popular social network for cannabis enthusiasts, is taking another shot at getting listed on the Nasdaq.…
News April 11
Latest Sponsored
